1. We have investigated the ability of bovine brain S.100, and of three related proteins from sheep aorta smooth muscle, to confer Ca2+-sensitivity on thin filaments reconstituted from smooth-muscle actin, tropomyosin and caldesmon. 2. At 37°C in pH 7.0 buffer containing 120 mM-KCl, approximately stoichiometric amounts of S.100 rc ersed caldesmon's inhibition of the activation of myosin MgATPase by smooth-muscle actin-tropomyosin. The [S.100] which reversed by 50 % the inhibition by caldesmon (the E.C.50) was 2.5 ,tM when [caldesmon] = 2-3 ,tM in the assay mixture. When [KCI] was decreased to 70 mm, E.C.50 = 11.5 /SM; at 25°C in 70 mM-KCl, up to 20,uM-S. 100 had no effect. When skeletalmuscle actin rather than smooth-muscle actin was used to reconstitute thin filaments, 20 ,#M-S. 100 did reverse inhibition by caldesmon, at 25°C in buffer containing 70 mM-KCl. This dependence on conditions is also characteristic of the calmodulin-caldesmon interaction. 3. These results suggested that S. 100 or a related protein might interact with caldesmon in smooth muscle. We therefore attempted to prepare such a protein from sheep aorta. Three proteins were purified: an Mr-17 000 protein (yield 16 mg/kg), an abundant Mr-I 1000 protein (yield 48 mg/kg), and an Mr-9000 protein (yield 4 mg/kg). Neither of the last two low-Mr proteins had any effect on activation of myosin MgATPase by reconstituted thin filaments. The protein of Mr 17000 had Ca2+-sensitizing activity, and behaved exactly like brain calmodulin in the assay system.
INTRODUCTION
The contraction of smooth muscle is controlled by the intracellular concentration of free Ca2+. The actomyosin contractile apparatus of smooth muscle is regulated by Ca2+ [1, 2] , which binds to regulatory proteins; distinct systems control the actinbased thin filaments and the thick (myosin) filaments. The Ca2+-dependent regulatory component of the well-studied myosinlinked system is known to be calmodulin [3] . However, the Ca2+-binding component of the thin filaments has never been identified. In addition to actin and tropomyosin, 'native' Ca2+-regulated thin filaments [4] , isolated intact from smooth muscles, contain the regulatory protein caldesmon [5, 6] , at a ratio of 1 molecule of caldesmon per 16 actin monomers [7] . Experiments on the reconstitution of purified smooth-muscle proteins into synthetic thin filaments have shown that caldesmon binds to actintropomyosin and inhibits its activation of myosin MgATPase [8, 9] . The mechanism of regulation in intact native thin filaments likewise depends on caldesmon [10] , and has been demonstrated with native thin filaments from vascular, visceral and uterine smooth muscle [6] . This inhibition is not Ca2+-sensitive, but can be rendered Ca2+-dependent by a suitable Ca2+-binding regulatory protein which can bind to caldesmon, reversing its inhibition of actin-tropomyosin. Caldesmon was originally isolated as a calmodulin-binding protein [5] , and a Ca2`-sensitive thin-filament system can be reconstituted by using brain calmodulin [8, 11, 12] .
However, it is by no means certain that native thin filaments are regulated by calmodulin; the calmodulin-regulated system is a poor mimic of the native Ca2+-sensitive thin filaments [13] [14] [15] . The binding of caldesmon to actin-tropomyosin has been shown to be the same in native thin filaments as in the reconstituted system [7] , and the discrepancies between the native and synthetic systems must be ascribed to the calmodulin. A large excess of calmodulin over caldesmon is required, except at 37°C in buffers containing 120 mM-KCI [9] , whereas the native thin filaments are more Ca2+-sensitive at lower temperatures [7] , and do not contain the large amounts of calmodulin which would be required. The Ca2+-sensitizing factor of the native filaments is retained after washes in EGTA, yet calmodulin only binds to caldesmon in the presence of Ca2+ [16] . Furthermore, crude Ca2+-sensitizing preparations from aorta can regulate MgATPase in the reconstituted system under conditions (25°C and 70 mM-KCI-containing buffer) where calmodulin cannot [16] : this Ca2+-sensitizing activity is rapidly destroyed at 80°C [15] , whereas the calmodulin-caldesmon interaction is very heat-stable [17] . However, reconstitution of Ca2+-sensitive thin filaments has never been demonstrated with a pure protein from smooth muscle. We have therefore investigated the properties of Ca2+-binding proteins other than calmodulin, in order to identify the intrinsic Ca2+-dependent regulator of the thin filaments. S.100 proteins belong to the 'E-F hand' group of Ca2+-binding proteins and are found in various types of mammalian cell as homo-and hetero-dimers of a and , subunits [18, 19] . S.100 proteins have been reported to regulate diverse cellular processes by binding to target proteins in a Ca2+-dependent manner [20, 21] . Recently brain S.100 protein has been shown to bind to caldesmon and to reverse caldesmon inhibition [22, 23] , and it has been suggested that S.100 may be the physiological regulator of caldesmon [22] .
We have examined the regulation of reconstituted thin filaments by S.100 from brain, and have investigated whether smooth muscle contains substantial amounts of S.100 or any similar protein, which could be responsible for thin-filamentlinked regulation of actomyosin. 18.4
Caldesmon regulation by S. 100 proteins about 10-fold. The resulting protein pellet was resuspended in 500 ml of 50 mM-Tris/HCI, pH 8.0, containing enzyme inhibitors as above, then dialysed against column buffer (50 mM-Tris/HCI, pH 7.5, 10 mM-2-mercaptoethanol). The sample was clarified by centrifugation (45000 g for 1 h), 1 M-CaCl2 stock was added to give 10 mM-CaCI2, and the sample was applied at 15 ml/h to a 2.5 cm x 20 cm phenyl-Sepharose column. The column was washed with 500 ml of column buffer containing 0.1 mM-CaCI2, then with 150 ml of column buffer containing 0.1 mM-CaCl2 and 0.5 M-NaCl, and again with 150 ml of the buffer without NaCI. . Mr values were determined from densitometric scans of4-30 % Pharmacia pre-cast gels. The gels were stained with Coomassie Blue. Protein concentrations were measured by the Lowry method. Molar concentrations of S.100, and of the smooth-muscle protein of Mr 11000, were calculated on the assumption that the proteins were dimers.
Preparation of contractile proteins Vascular smooth-muscle proteins were prepared from sheep aorta. F-actin and caldesmon were prepared by fractionation of thin filaments by the method of Smith & Marston [8] or by applying the same fractionation procedure to heat-treated extract [26, 27] . Tropomyosin was prepared by a modification [8] of the method of Bailey [281. Myosin and F-actin were purified from rabbit skeletal muscle by standard procedures [29, 30] .
Reversal of caldesmon inhibition of actin-activated myosin MgATPase Ca2+-sensitizing activity was assayed as described by Pritchard & Marston [16] . Tubes contained 1-1.5 /M rabbit skeletal-muscle myosin, 24 uM actin (smooth or skeletal muscle) and 6 4uM aorta tropomyosin, in 200 ,1 of 'ATPase' buffer containing 70 mm-or 120 mM-KCI, 5 mM-MgCI2, 10 mM-NaN., 5 mM-K2Pipes, pH 7.0 at assay temperature, 1 mM-dithiothreitol. The reaction was initiated by adding MgATP to 2 mm and terminated by addition of an 80 u1 portion of the sample to 0.5 ml of 5% (w/v) trichloroacetic acid; the released Pi was assayed by colorimetry of a phosphomolybdate complex as described by Taussky & Schorr [31] . Each caldesmon preparation was titrated in a preliminary assay to determine the minimum concentration required for maximal ATPase inhibition (typically 1.5-2.4 /LM, depending on assay conditions); this concentration of caldesmon was used to reconstitute thin filaments with potential Ca2+-sensitizing factors.
RESULTS

Isoform composition of brain S.100
A peak eluted from phenyl-Sepharose at approx. pCa 5.5 was mainly composed of a protein of Mr 10000 by SDS/PAGE. Brain S.100 was purified from this peak by f.p.l.c. on a Mono-Q column at pH 7.5 (50 mM-Tris/HCl buffer). S.100 was eluted in a broad peak over NaCl concentrations between 270 and 340 mm.
This mixed-isoform peak was used for experiments with reconstituted thin filaments. Subdivision of the S.100 peak into two pools, and a further stage of Mono-Q chromatography, allowed the isoforms to be obtained separately. The preparation tested contained S. 100a0 (a2 homodimer), 4.5 % (eluted between 270 and 280mM-NaCl), S.lOOa (a-,I heterodimer), 10.5% (280-300 mM-NaCl), and S. lOOb (f82 homodimer), 85 % (300-320 mmNaCl). Calmodulin dissociated from phenyl-Sepharose at approx. pCa 6.0 and in subsequent Mono-Q chromatography was eluted between 300 and 380 mM-NaCI.
Purification of S.100-like proteins from aorta Elution of the phenyl-Sepharose column with EDTA produced a mixture of proteins (Fig. la) , from which three low-Mr proteins (Figs. la, lc and ld) were purified by anion-exchange on Mono-Q (Fig. lb ). An Mr-1 1500 (Fig. lc, lane x) protein was eluted from Mono-Q between 170 and 180 mM-NaCl and was obtained in a yield of approx. 48 mg/kg wet wt. of aorta. An M,-17000
( Fig. lc, lane y) protein was eluted between 340 and 380 mmNaCl, in a yield of approx. 16 mg/kg. A protein (Fig. ld, lane z) of approx. Mr 9000 (yield approx. 4 mg/kg) was eluted between 400 and 440 mM-NaCl.
Reconstitution of Ca2+-sensitive thin filaments with brain S.100
In the presence of 0.1 mM-CaCl2, but not in 1 mM-EGTA, brain S.100 reversed the inhibition by caldesmon of the smoothmuscle actin-tropomyosin-activated myosin MgATPase (Fig. 2) . Its ability to do so depended critically on experimental conditions ( Fig. 2; Table 1 ). At 37°C in buffer containing 120 mM-KCI, approximately stoichiometric amounts of S.100 reversed caldesmon inhibition, whereas as 37°C in buffer containing 70 mm-KCI reversal of caldesmon inhibition required a considerable molar excess of S.100 over caldesmon (Table 1 ). S.100 at up to 20 uM appeared ineffective at 23°C in buffer containing 70 mi-KCI. The same effect of conditions was observed with four independent preparations of S.100. When thin filaments were reconstituted by using skeletal-muscle actin with smooth-muscle caldesmon and tropomyosin, the Ca2+-sensitivity conferred by reversing inhibition by caldesmon of skeletal-muscle actin (M), yet had no effect on caldesmon inhibition of smooth-muscle actin (A). In the presence of 1 mM-EGTA, S.100 had no effect (-, *). Assay tubes contained 0.4 mg of skeletal-muscle myosin/ml, the MgATPase activity of which was activated by 38 (Fig. 4) . Table 1 for comparison). Symbols S and * indicate presence of 1 mM-EGTA. Assay conditions are given in Fig. 2 legend.
The abundant protein of Mr 11 000, from the same preparation, had no significant effect on ATPase rate under any conditions used (Fig. 4) . Two independent preparations of this protein were made from sheep aorta; the behaviour of the proteins in the ATPase assay was similar in either case.
The third protein, of Mr 9000, was tested at up to 24 /SM in buffer containing 120 mM-KCI at 37°C, but had no effect on ATPase rate in either the presence or the absence of Ca2+ (results not shown).
DISCUSSION
Brain S.100 interaction with caldesmon Brain S. 100, like brain calmodulin, conferred Ca2+-sensitivity on a reconstituted smooth-muscle thin-filament system. S.100. binds to caldesmon in the presence of Ca2+ [22, 23] ; presumably, the Ca2+-S.100-caldesmon complex no longer inhibits actin-
Caldesmon regulation by S.100 proteins 823 tropomyosin. In our experiments, inhibition by 2-3 /SM-caldesmon was, under optimal conditions, reversed by approximately stoichiometric amounts of S.100. Thus the binding constant between S.100 and caldesmon is probably at least 106 M-1. We did not test S.100 isoforms separately, but our preparation contained mainly f-subunit, as reported for bovine brain [20, 21, 25] , so its activity probably involved dimers containing that subunit. The possible activity of the a-subunit cannot be assessed from our data. The pattern of dependence on temperature and ionic strength is identical with S.100 or calmodulin [9] . Binding studies have clarified why calmodulin behaves in this way. At 37°C, a Ca21 calmodulin-caldesmonactin-tropomyosin complex can be formed, which activates myosin MgATPase fully [16] . At 25 OC this complex is not formed; reversal of caldesmon inhibition then depends on the competition for binding to caldesmon between Ca2+ -calmodulin (the binding constant between Ca2+ * calmodulin and caldesmon is approx. 106 M-1) and actin-tropomyosin (the binding constant between caldesmon and actin-tropomyosin is approx. 107 M-1), and consequently a large excess of calmodulin is required [9, 16] . It seems likely that the mechanism of S.100-mediated Ca2+-sensitivity is both qualitatively and quantitatively similar. It appears to be quite unusual for calmodulin and S.100 to interact with the same target protein in such a similar fashion [18] [19] [20] .
We have considered that the calmodulin-caldesmon interaction does not account for the Ca2+-sensitivity of native thin filaments [13, 15] . Skripnikova & Gusev [22] reported that S.100 could regulate reconstituted thin fialments at 25°C in buffer of low ionic strength, but calmodulin did not. They suggested that S.100 might be the intrinsic Ca2+-sensitizing factor of native thin filaments. We also found that, if thin filaments were reconstituted with skeletal-muscle actin, smooth-muscle tropomyosin and caldesmon, then S.100 could indeed reverse caldesmon inhibition at 25 'C. However, this also occurred with brain calmodulin, and is a result of the greater tendency for caldesmon to bind to skeletal-muscle actin without inhibiting it [9, 11, 12] . Since caldesmon and skeletal-muscle actin are unlikely to interact in cells, this observation may not be physiologically significant. We cannot account for the lack of activity of calmodulin in the experiments of Skripnikova & Gusev [22] , except that their source of caldesmon and other experimental details differ from ours. Our data do not indicate that reconstitution of thin filaments with S.100 rather than calmodulin produces a better model of the native filaments. [33, 34] . Immunochemical studies have detected only low amounts of S.100 in smooth muscles [20, 21] . However, other S.100-like proteins might be present in smooth muscle, but might not crossreact with antibodies to brain S.100. Hydrophobic-interaction chromatography is a well-known technique for preparing Ca2+-binding proteins such as calmodulin or annexins for smooth muscle [35] . The fraction of smoothmuscle proteins eluted from phenyl-Sepharose with EDTA contained numerous protein species, presumably including potential Ca2+-binding proteins such as calmodulin. Our attempts to prepare smooth-muscle S.100 produced three protein species, none of which was identical with brain S.100 isoforms.
One of these proteins was of the same Mr as calmodulin (17000), had the same chromatographic properties, and behaved in exactly the same way as brain calmodulin in the reconstituted thin-filament system. It seems highly likely that this protein was smooth-muscle calmodulin; our data do not support the theory [36, 37] Parvalbumin as such may be absent from smooth muscle [38] . Oncomodulin has a similar Mr (reported as 11 700), and is closely related to parvalbumins [39] , though it has not been shown to occur in normal adult tissues [40] . There are several other Ca2+ binding proteins of similar Mr, including the calgranulins [41] , the M,-10 500 calcyclin-like protein [42] and calbindin '9k' (M, 8800; [43] ), but the reported distribution of these proteins does not include smooth muscle. The protein of Mr 11000 may by the SMCaBP-11 recently reported by Mani & Kay [44] , since the apparent Mr, abundance and elution from anion-exchange were similar. Is has been suggested that this protein may have a regulatory role [44] . However, its functions probably do not include regulation of caldesmon, since it had no effect on ATPase in our reconstituted thin-filaments system, even though the protein of Mr 17000 was active, suggesting that the preparation method did not destroy activity. The identity of the protein of Mr 9000 is more uncertain, as it does not seem to correspond to any reported smooth-muscle protein; this protein did not appear to interact with caldesmon. We found no evidence, therefore, that aorta smooth muscle contained a sufficient concentration of S.100 to regulate caldesmon in the thin filaments. Nevertheless, S.100 is potentially an efficient regulator of the caldesmon-actin interaction under physiological conditions. Some types of nonmuscle cells may contain both S.100 and the lower-Mr caldesmon isoform, and caldesmon-S. 100 interactions could be important in regulating cellular functions in such cells. Neither of the lowMr proteins which we isolated from aorta had any effects on caldesmon in reconstituted thin filaments, but these negative results do not, of course, rule out the existence of any alternative regulatory protein which might be involved in controlling smooth-muscle actomyosin.
